askc202
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started May 31, 2022 (NCT05306132)
Timeline
Indications
Mechanism of action
GNRHR inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07109531 | Phase 3 | Aug 31, 2025 | Jiangsu Aosaikang Pharmaceutical Co., Ltd. |
| NCT05306132 | Phase 1 | May 31, 2022 | Huazhong University of Science and Technology, Jiangsu Aosaikang Pharmaceutical Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Aosaikang Pharmaceutical Co., Ltd. | For profit | 2 | 2 | 2 | 2022 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1